Logo image of HYPD

HYPERION DEFI INC (HYPD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HYPD - US30234E2037 - Common Stock

2.83 USD
-0.04 (-1.39%)
Last: 1/21/2026, 8:00:03 PM
2.7973 USD
-0.03 (-1.16%)
After Hours: 1/21/2026, 8:00:03 PM
Fundamental Rating

2

HYPD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of HYPD have multiple concerns. HYPD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year HYPD has reported negative net income.
  • HYPD had a negative operating cash flow in the past year.
  • HYPD had negative earnings in each of the past 5 years.
  • In the past 5 years HYPD always reported negative operating cash flow.
HYPD Yearly Net Income VS EBIT VS OCF VS FCFHYPD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -60.17%, HYPD is doing worse than 64.92% of the companies in the same industry.
  • HYPD has a Return On Equity of -70.41%. This is comparable to the rest of the industry: HYPD outperforms 43.98% of its industry peers.
Industry RankSector Rank
ROA -60.17%
ROE -70.41%
ROIC N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HYPD Yearly ROA, ROE, ROICHYPD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • HYPD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYPD Yearly Profit, Operating, Gross MarginsHYPD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K

3

2. Health

2.1 Basic Checks

  • HYPD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HYPD has been increased compared to 1 year ago.
  • The number of shares outstanding for HYPD has been increased compared to 5 years ago.
  • The debt/assets ratio for HYPD is higher compared to a year ago.
HYPD Yearly Shares OutstandingHYPD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
HYPD Yearly Total Debt VS Total AssetsHYPD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • HYPD has an Altman-Z score of -3.66. This is a bad value and indicates that HYPD is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -3.66, HYPD is doing worse than 61.78% of the companies in the same industry.
  • HYPD has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of HYPD (0.11) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -3.66
ROIC/WACCN/A
WACC11.23%
HYPD Yearly LT Debt VS Equity VS FCFHYPD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

2.3 Liquidity

  • A Current Ratio of 2.25 indicates that HYPD has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.25, HYPD perfoms like the industry average, outperforming 41.88% of the companies in the same industry.
  • HYPD has a Quick Ratio of 2.25. This indicates that HYPD is financially healthy and has no problem in meeting its short term obligations.
  • HYPD's Quick ratio of 2.25 is in line compared to the rest of the industry. HYPD outperforms 47.12% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 2.25
HYPD Yearly Current Assets VS Current LiabilitesHYPD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.98% over the past year.
  • HYPD shows a strong growth in Revenue. In the last year, the Revenue has grown by 1407.89%.
  • The Revenue for HYPD have been decreasing by -84.00% on average. This is quite bad
EPS 1Y (TTM)4.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.22%
Revenue 1Y (TTM)1407.89%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%18806.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.36% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 98.76% on average over the next years. This is a very strong growth
EPS Next Y33.51%
EPS Next 2Y21.63%
EPS Next 3Y20.36%
EPS Next 5YN/A
Revenue Next Year-7.67%
Revenue Next 2Y87.93%
Revenue Next 3Y98.76%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HYPD Yearly Revenue VS EstimatesHYPD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
HYPD Yearly EPS VS EstimatesHYPD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -50 -100

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HYPD. In the last year negative earnings were reported.
  • Also next year HYPD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HYPD Price Earnings VS Forward Price EarningsHYPD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYPD Per share dataHYPD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40 -50

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HYPD's earnings are expected to grow with 20.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.63%
EPS Next 3Y20.36%

0

5. Dividend

5.1 Amount

  • HYPD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HYPERION DEFI INC

NASDAQ:HYPD (1/21/2026, 8:00:03 PM)

After market: 2.7973 -0.03 (-1.16%)

2.83

-0.04 (-1.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)04-13
Inst Owners9%
Inst Owner ChangeN/A
Ins Owners26.18%
Ins Owner Change75.69%
Market Cap22.92M
Revenue(TTM)57.30K
Net Income(TTM)-49.82M
Analysts82.5
Price Target5.99 (111.66%)
Short Float %32.55%
Short Ratio6.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)27.81%
EPS NQ rev (3m)27.81%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-62.5%
Revenue NQ rev (3m)-62.5%
Revenue NY rev (1m)-81.57%
Revenue NY rev (3m)-81.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 400.05
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-50.93
EYN/A
EPS(NY)-26.52
Fwd EYN/A
FCF(TTM)-10.18
FCFYN/A
OCF(TTM)-2.08
OCFYN/A
SpS0.01
BVpS8.74
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -60.17%
ROE -70.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-514.41%
ROA(5y)-328.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5816.13%
Cap/Sales 114546%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 2.25
Altman-Z -3.66
F-Score4
WACC11.23%
ROIC/WACCN/A
Cap/Depr(3y)219.51%
Cap/Depr(5y)330.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.22%
EPS Next Y33.51%
EPS Next 2Y21.63%
EPS Next 3Y20.36%
EPS Next 5YN/A
Revenue 1Y (TTM)1407.89%
Revenue growth 3Y-84%
Revenue growth 5YN/A
Sales Q2Q%18806.25%
Revenue Next Year-7.67%
Revenue Next 2Y87.93%
Revenue Next 3Y98.76%
Revenue Next 5YN/A
EBIT growth 1Y-47.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-88.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-218%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.6%
OCF growth 3YN/A
OCF growth 5YN/A

HYPERION DEFI INC / HYPD FAQ

What is the fundamental rating for HYPD stock?

ChartMill assigns a fundamental rating of 2 / 10 to HYPD.


Can you provide the valuation status for HYPERION DEFI INC?

ChartMill assigns a valuation rating of 1 / 10 to HYPERION DEFI INC (HYPD). This can be considered as Overvalued.


Can you provide the profitability details for HYPERION DEFI INC?

HYPERION DEFI INC (HYPD) has a profitability rating of 0 / 10.